| Issue Date | Title | Author(s) |
| 2020-12 | Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia. | Dun, MD; Mannan, A; Rigby, CJ; Butler, S; Toop, HD; Beck, D; Connerty, P; Sillar, J; Kahl, RGS; Duchatel, RJ; Germon, Z; Faulkner, S; Chi, M; Skerrett-Byrne, D; Murray, HC; Flanagan, H; Almazi, JG; Hondermarck, H; Nixon, B; De Iuliis, G; Chamberlain, J; Alvaro, F; de Bock, CE; Morris, JC; Enjeti, AK; Verrills, NM |
| 2013-05-23 | Functional characterization of cancer-associated Gab1 mutations. | Ortiz-Padilla, C; Gallego-Ortega, D; Browne, BC; Hochgräfe, F; Caldon, CE; Lyons, RJ; Croucher, DR; Rickwood, D; Ormandy, CJ; Brummer, T; Daly, RJ |
| 2021-03-03 | A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma | Cheung, BB; Kleynhans, A; Mittra, R; Kim, PY; Holien, JK; Nagy, Z; Ciampa, OC; Seneviratne, JA; Mayoh, C; Raipuria, M; Gadde, S; Massudi, H; Wong, IPL; Tan, O; Gong, A; Suryano, A; Diakiw, SM; Liu, B; Arndt, GM; Liu, T; Kumar, N; Sangfelt, O; Zhu, S; Norris, MD; Haber, M; Carter, DR; Parker, MW; Marshall, GM |
| 2021-07-19 | The Pandora’s Box of novel technologies that may revolutionize lung cancer | Rad, HS; Rad, HS; Shiravand, Y; Radfar, P; Arpon, D; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2018-08 | MASTL overexpression promotes chromosome instability and metastasis in breast cancer. | Rogers, S; McCloy, RA; Parker, BL; Gallego-Ortega, D; Law, AMK; Chin, VT; Conway, JRW; Fey, D; Millar, EKA; O'Toole, S; Deng, N; Swarbrick, A; Chastain, PD; Cesare, AJ; Timpson, P; Caldon, CE; Croucher, DR; James, DE; Watkins, DN; Burgess, A |
| 2020-10 | Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer. | Kapeleris, J; Kulasinghe, A; Warkiani, ME; Oleary, C; Vela, I; Leo, P; Sternes, P; O'Byrne, K; Punyadeera, C |
| 2023-04-20 | Is it time we changed the way we manage melanoma in situ of the trunk and limbs? | Smith, H; Hussain, W |
